Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Equinor in connection with divestment of shares in Lundin Petroleum and investment
Mandate

Vinge advised Equinor in connection with divestment of shares in Lundin Petroleum and investment

July 12, 2019 Capital Markets and Public M&A

The Norwegian energy company Equinor ASA announced on 7 July that it had agreed with Lundin Petroleum AB (publ) to divest around 54.5 million shares in Lundin Petroleum for a total consideration of around USD 1.56 billion and to acquire 2.6% of the development project Johan Sverdrup for a cash consideration of USD 910 million.  

Equinor ASA is a global energy company with more than 20,000 employees and business in more than 30 countries. Equinor is the largest oil and gas operator in Norway, one of the largest offshore operators globally and has a growing portfolio of renewable assets in wind and solar power.
 
Vinge’s team consisted of Dain Hård Nevonen, David Andersson, Johan Karlsson och Anna Grigorian.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026